<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Senators to propose ban on drug ads to consumers, WSJ reports

PremiumThe Fly

2d ago

RFK Jr. names eight members to vaccine panel, WSJ reports

PremiumThe Fly

3d ago

RFK Jr. names new CDC vaccine advisory panel picks, STAT reports

PremiumThe Fly

3d ago

Quantum Leap: Nvidia CEO says quantum computing technology at inflection point

PremiumThe Fly

3d ago

IBM

PremiumRatingsAstraZeneca’s Strong Strategic Positioning and Growth Potential Justifies Buy Rating

4d ago

Mineralys Therapeutics initiated with a Hold at Jefferies

The Fly

Mineralys Therapeutics initiated with a Hold at Jefferies

4d ago

MLYS

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

The Fly

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

4d ago

RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members

PremiumThe Fly

5d ago

RFK Jr. removes members of vaccine-advising CDC panel, CNBC reports

PremiumThe Fly

5d ago

AstraZeneca doses first patient in DESTINY-Endometrial01 trial

PremiumThe Fly

6d ago

IonQ announces results from pact with AstraZeneca, Amazon.com and Nvidia

PremiumThe Fly

6d ago

AMZN

PremiumThe FlyStudy finds GLP-1s may have link to eye disease, STAT reports

9d ago

LLY

AstraZeneca’s Calquence approved in EU for treating CLL

The Fly

AstraZeneca’s Calquence approved in EU for treating CLL

9d ago

Vaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says

The Fly

Vaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says

9d ago

AstraZeneca’s Calquence Regimen Approved in EU for Untreated CLL

PremiumCompany Announcements

9d ago

PremiumRatings

AstraZeneca’s Promising Outlook: Buy Rating Backed by Positive DESTINY-Breast09 Trial Results and 35.5% Upside Potential

10d ago

Perrigo appoints Matt Winterman as Product Supply, Operation Strategy Officer

PremiumThe Fly

11d ago

Bristol deal takes out ‘key’ potential buyer of Summit Therapeutics, says Truist

GSK

PremiumThe Fly

12d ago

PremiumCompany AnnouncementsAstraZeneca Announces Share Capital and Voting Rights Update

12d ago

AstraZeneca says Enhertu combo showed PFS improvement over THP in trial

The Fly

AstraZeneca says Enhertu combo showed PFS improvement over THP in trial

13d ago

AstraZeneca, Daiichi Sankyo announce results from DESTINY-Breast09 Phase III

The Fly

AstraZeneca, Daiichi Sankyo announce results from DESTINY-Breast09 Phase III

13d ago